DW News published this video item, entitled “FDA approves controversial Biogen Alzheimer’s drug | DW News” – below is their description.
US government health officials have approved the first new drug for Alzheimer’s disease in nearly twenty years. Regulators say the drug, which will be known as Aduhelm, is the first treatment that targets the causes of the disease, rather than its symptoms. But the approval is controversial – with some experts saying there’s not enough firm evidence of real benefits.DW News YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.